Page 2 - Gsk

Sanofi, GSK and Haleon lead $40-billion rout on heartburn drug

Sanofi fell 13% on Thursday, taking its 2-day decline to 20%; GSK slid 6.9%

Sanofi, GSK say Covid booster shot works better against Omicron variant

The companies point to the risk of new variants and waning immunity that could lead to an increase in demand for additional booster shots in some populations.

US pulls GSK's Covid drug as omicron sibling dominates cases

GlaxoSmithKline's IV drug for Covid-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most US cases, federal health regulators said

Sanofi, GSK to seek regulatory approval for Covid vaccine candidate

Sanofi-GSK's shot relies on a conventional protein-based approach, compared with the newer mRNA technology used in established Covid-19 vaccines from Pfizer-BioNTech and Moderna

CCPA passes order for discontinuation of Sensodyne ads in India

Consumer protection regulator CCPA has passed an order against GlaxoSmithKline Consumer Healthcare Ltd directing it to discontinue advertisements of Sensodyne products in India for flouting norms.

Unilever to sell slow-growth brands as it weighs higher bid for GSK unit

The Dove soap owner said Monday it will announce a revamp of its structure later this month

Unilever eyes GSK's consumer goods arm in possible $68-bn deal

Unilever confirms interest in GSK assets, says GSK consumer business would be 'strong strategic fit'; UK's Sunday Times says 50 billion-pound bid rejected in late 2021

How the world's first malaria vaccine will protect against the parasite

This vaccine has been in development for 30 long years

GSK, CureVac's next-gen Covid vaccine shows promise in monkey trial

The encouraging news on its "second-generation" vaccine gave CureVac's German-listed shares an 8% lift, as the stock gradually recovers from a slump in June

Sanofi-GSK Covid-19 vaccine gets nod to start phase-3 trials in India

India part of 35,000 volunteer global efficacy trial

GSK's drugs arm to get $11 billion windfall from consumer spin-off

Investors have been waiting for details of the separation

Activist investor Elliott takes multibillion pound stake in GSK: Report

Shares in GSK erased losses and traded more than 7% higher

GSK fires former US govt vaccine head Slaoui over harassment allegation

GlaxoSmithKline has dismissed Moncef Slaoui as chairman of a company controlled by the British drugmaker after an internal investigation found he had sexually harassed an employee several years ago

GSK fires former US govt vaccine head Slaoui over harassment allegation

Former U.S. President Donald Trump appointed Slaoui to lead his administration's effort to produce and distribute COVID-19 vaccines last year

GSK, CureVac to develop Covid-19 vaccines aimed at new variants

Drugmaker GlaxoSmithKline said Wednesday it will work with a German biopharmaceutical company to develop new vaccines targeting emerging variants of COVID-19

British firm GSK to move malaria vaccine production to Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the malaria vaccine

GSK transfers malaria vaccine production to India's Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the vaccine

India Inc gets back to office cautiously, even as many MNCs remain shut

Many are testing hybrid models to ensure safety and hygiene; seat-booking module introduced in some companies

COVAX gains access to 2 billion doses of vaccines for 190 member economies

First deliveries are expected to begin in the first quarter of 2021 depending upon regulatory approvals and readiness of countries for delivery

Sanofi-GSK delay Covid-19 vaccine to late 2021 in setback to global fight

The two companies said they planned to start another study next February, hoping to come up with a more effective vaccine